Jump to main content
Jump to site search

Issue 7, 2012
Previous Article Next Article

Pharmaceutical crystallography: is there a devil in the details?

Author affiliations

Abstract

Modern instruments for small-molecule crystallography continue to become more sophisticated and more automated. This technical progress provides a basis for frontier research in chemical and pharmaceutical crystallography, but it also encourages analytical crystallographers to become more complacent and more reliant on the automated methods. This leads to problems in the literature, particularly for disordered structures, where it is possible for automated systems to handle only part of the diffraction pattern, whilst ignoring the features that reveal the disorder. Three examples are presented for pharmaceutical compounds, and the potential importance of the “details” in pharmaceutical crystallography is discussed.

Graphical abstract: Pharmaceutical crystallography: is there a devil in the details?

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 12 Dec 2011, accepted on 27 Jan 2012 and first published on 22 Feb 2012


Article type: Highlight
DOI: 10.1039/C2CE06662A
Citation: CrystEngComm, 2012,14, 2363-2366
  •   Request permissions

    Pharmaceutical crystallography: is there a devil in the details?

    A. D. Bond, CrystEngComm, 2012, 14, 2363
    DOI: 10.1039/C2CE06662A

Search articles by author